VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MCYMercury General Corporation
$107.47$6.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMCYQuarterly Financials

Mercury General Corporation (MCY) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Mercury General Corporation (MCY) quarterly income statement — complete revenue, gross profit & net income history

MCY Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue1.54B1.54B1.58B1.48B1.39B1.37B1.53B1.3B1.27B1.37B1.07B1.08B
Revenue Growth %10.47%12.41%3.56%13.25%9.4%-0.61%43.67%20.47%15.14%19.36%18.32%37.88%
Medical Costs & Claims932.95M226.67M1.12B1.17B1.45B1.15B1.15B1.14B1.1B1.06B1.01B1.07B
Medical Cost Ratio %60.59%14.76%70.6%79.03%103.99%84.44%75.06%87.39%86.34%76.86%94.38%98.83%
Gross Profit606.86M1.31B466.02M309.97M-55.65M212.54M381.64M164.6M174.08M318.15M59.88M12.68M
Gross Margin %39.41%85.24%29.4%20.97%-3.99%15.56%24.94%12.61%13.66%23.14%5.62%1.17%
Gross Profit Growth %1190.41%515.93%22.11%88.32%-131.97%-33.19%537.33%1198.09%1287.87%444.02%206.84%106.42%
Operating Expenses371.21M1.06B115.7M103.22M86.64M89.04M94.58M89.5M84.86M80.2M75.11M73.89M
OpEx / Revenue %24.11%69.04%7.3%6.98%6.22%6.52%6.18%6.86%6.66%5.83%7.05%6.82%
Depreciation & Amortization19.84M21.27M18.77M17.7M17.24M19.59M19.11M17.4M17.34M18.09M18.24M18.51M
Combined Ratio %84.7%83.79%77.9%86.01%110.21%90.96%81.24%94.25%93%82.69%101.43%105.65%
Operating Income235.65M248.88M350.32M206.75M-142.3M123.5M287.06M75.1M89.22M237.94M-15.23M-61.21M
Operating Margin %15.3%16.21%22.1%13.99%-10.21%9.04%18.76%5.75%7%17.31%-1.43%-5.65%
Operating Income Growth %265.61%101.52%22.03%175.31%-259.49%-48.1%1984.98%222.69%243.72%1472.07%88.19%77.44%
EBITDA255.49M270.15M369.09M224.45M-125.05M143.09M306.17M92.5M106.56M256.03M3.01M-42.7M
EBITDA Margin %16.59%17.59%23.29%15.19%-8.97%10.47%20.01%7.09%8.36%18.63%0.28%-3.94%
Interest Expense6.82M7.06M7.18M7.2M7.19M7.54M7.72M7.8M7.77M7.77M5.92M5.55M
Non-Operating Income0-7.06M-7.18M-7.2M-7.19M-7.54M-7.72M-7.8M-7.77M-7.77M-5.92M-5.55M
Pretax Income235.65M248.88M350.32M206.75M-142.3M123.5M287.06M75.1M89.22M237.94M-15.23M-61.21M
Pretax Margin %15.3%16.21%22.1%13.99%-10.21%9.04%18.76%5.75%7%17.31%-1.43%-5.65%
Income Tax45.23M46.33M69.92M40.28M-33.97M22.43M56.21M12.53M15.76M46.55M-7M-19.67M
Effective Tax Rate %19.19%18.62%19.96%19.48%23.87%18.16%19.58%16.68%17.66%19.56%45.98%32.13%
Net Income190.42M202.55M280.4M166.47M-108.33M101.07M230.86M62.57M73.46M191.39M-8.23M-41.54M
Net Margin %12.37%13.19%17.69%11.26%-7.77%7.4%15.08%4.79%5.77%13.92%-0.77%-3.84%
Net Income Growth %275.78%100.41%21.46%166.07%-247.46%-47.19%2906.08%250.61%262.21%2927.09%91.63%80.28%
EPS (Diluted)3.443.665.063.01-1.961.824.171.131.333.46-0.15-0.75
EPS Growth %275.51%101.1%21.34%166.37%-247.37%-47.4%2880%250.67%262.2%2983.33%91.57%80.26%
EPS (Basic)3.443.665.063.01-1.961.834.171.131.333.46-0.15-0.75
Diluted Shares Outstanding55.39M55.39M55.39M55.39M55.39M55.38M55.38M55.38M55.37M55.37M55.37M55.37M